Liu, L., Liu, Y., Chen, X., Wang, M., Zhou, Y., Zhou, P., . . . Zhu, F. (2017). Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma. Oncotarget.

Liu, Lijuan, Youyi Liu, Xiaobei Chen, Miao Wang, Yan Zhou, Ping Zhou, Wenxin Li, and Fan Zhu. "Variant 2 of KIAA0101, Antagonizing Its Oncogenic Variant 1, Might Be a Potential Therapeutic Strategy in Hepatocellular Carcinoma." Oncotarget 2017.

Liu, Lijuan, et al. "Variant 2 of KIAA0101, Antagonizing Its Oncogenic Variant 1, Might Be a Potential Therapeutic Strategy in Hepatocellular Carcinoma." Oncotarget 2017.